If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

Share Price is delayed by 15 minutes
Get Live Data
556.00    -1.00 (-0.18%)
Bid:
555.00
Ask:
555.50
Spread: 0.50 (0.09%)
Market Cap: £2.46b
TATE Live PriceLast checked at - London Stock Exchange

Intraday Tate & Lyle Share Chart

Director/PDMR Shareholding

8 Jul 2015 14:52

Tate & Lyle PLC

Director/PDMR Shareholding

Tate & Lyle PLC (the “Company”) announces that it was informed yesterday that on 7 July 2015, a grant of options and awards over the Company’s ordinary shares of 25 pence each in the capital of the Company (“Shares”) was made to Persons Discharging Managerial Responsibilities (“PDMR”) and to an Executive Director as follows:

1. PDMRs

Name Role Number of Shares subject to option* Number of Shares subject to award*
Rowan Adams PDMR 35,000 -
Joan Braca PDMR - 90,000
Robert Gibber PDMR 110,000 -
Rob Luijten PDMR 80,000 -
Gabrielle Parisse PDMR - 70,000
Pierre Schoumacher PDMR - 70,000

* Options are generally granted to UK residents and awards to non-UK residents.

The above options and awards will only vest to the extent that certain Company-based financial performance criteria are satisfied over a performance period which runs from 1 April 2015 to 31 March 2016. No consideration is payable for the grant or exercise of the options or awards. Options and awards will be subject to a 12-month deferral period and continued employment to 31 March 2017.

2. Nick Hampton

As explained on pages 71 and 72 of the Company’s Annual Report 2015, Nick Hampton, Chief Financial Officer, was granted an award in the form of a nil cost option over 121,781 ordinary shares of 25 pence each in the capital of the Company (the “Award”).

The Award was granted in connection with Mr Hampton’s recruitment as Chief Financial Officer and is intended to honour the agreement (announced on 24 June 2014) to compensate him for incentive awards that he forfeited at his previous employer.

The Award which is within the shareholder approved remuneration policy (for recruitment) has been granted following consultation with major shareholders. As a condition of the grant of the Award, Mr Hampton has surrendered the compensatory Award C that was granted to him on 18 November 2014 with a face value at the time of £1.44m.

The Award will be available for exercise by Mr Hampton after 31 March 2017.

Following the grant of the Award, the incentive arrangements relating to the recruitment of Mr Hampton are as follows:

Award name Date of grant Number of Shares subject to option Vesting Date
Award A 18/11/2014 96,681 01/09/15
Award B 18/11/2014 96,680 01/09/16
Award C – replacement 07/07/2015 121,781 After 31/03/17

All the above transactions took place in London.

This notification is made in accordance with DTR 3.1.4R(1)(a) of the FCA’s Disclosure and Transparency Rules.

Lucie Gilbert

Company Secretary

8 July 2015

Note:

Extract from the announcement issued on 24 June 2014:

To compensate Nick for incentive awards that he will forfeit at PepsiCo Europe, Tate & Lyle will make him a one-off Restricted Stock Award (RSA) of £1,200,000 worth of shares in Tate & Lyle (delivered in two equal tranches on the first and second anniversaries of his employment with Tate & Lyle subject to achievement of performance conditions) (Award A and B). In addition, he will receive a PSP award in 2014 of £1,440,000 worth of shares in Tate & Lyle (Award C). The foregoing RSA and PSP award will be subject to forfeiture/repayment if he ceases to be employed in the first 36 months of employment due to his resignation or dismissal for cause.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150708005829/en/

Copyright Business Wire 2015

Date   Source Headline
1st May 202610:00 amRNSTotal Voting Rights
1st Apr 20264:00 pmRNSHolding(s) in Company
27th Mar 20262:00 pmRNSHolding(s) in Company
13th Mar 20264:00 pmRNSHolding(s) in Company
2nd Mar 20262:00 pmRNSHolding(s) in Company
26th Feb 20267:00 amRNSTrading Statement
23rd Feb 202610:00 amRNSHolding(s) in Company
17th Feb 202612:00 pmRNSHolding(s) in Company
21st Jan 20267:00 amRNSDirectorate change
15th Jan 20269:00 amRNSHolding(s) in Company
12th Jan 202610:00 amRNSHolding(s) in Company
7th Jan 20264:30 pmRNSDirector/PDMR Shareholding
7th Jan 20262:30 pmRNSBlock listing Interim Review
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
18th Dec 20252:00 pmRNSDirector/PDMR Shareholding
11th Dec 202512:18 pmRNSDirector/PDMR Shareholding
9th Dec 20259:00 amRNSHolding(s) in Company
27th Nov 202510:00 amRNSDirector/PDMR Shareholding
11th Nov 20254:30 pmRNSDirector/PDMR Shareholding
10th Nov 20252:40 pmRNSDirector Declaration
6th Nov 20257:00 amRNSHalf-year Financial Report
5th Nov 20252:15 pmRNSHolding(s) in Company
3rd Nov 20255:00 pmRNSHolding(s) in Company
29th Oct 20252:00 pmRNSHolding(s) in Company
23rd Oct 20254:15 pmRNSHolding(s) in Company
21st Oct 20253:30 pmRNSHolding(s) in Company
16th Oct 202512:00 pmRNSHolding(s) in Company
8th Oct 202512:00 pmRNSHolding(s) in Company
6th Oct 20254:30 pmRNSDirector/PDMR Shareholding
6th Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
3rd Oct 202510:00 amRNSDirector/PDMR Shareholding
1st Oct 20257:00 amRNSPre-close statement
2nd Sep 20258:00 amRNSTotal Voting Rights
11th Aug 20251:00 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSDirector/PDMR Shareholding
1st Aug 202511:00 amRNSTotal Voting Rights
24th Jul 20252:30 pmRNSResult of Annual General Meeting 2025
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
1st Jul 20253:30 pmRNSBlock listing Interim Review
1st Jul 20257:00 amRNSTate & Lyle Capital Markets Event
13th Jun 20253:00 pmRNSHolding(s) in Company
11th Jun 20254:30 pmRNSDirector/PDMR Shareholding
5th Jun 20252:30 pmRNSAnnual Financial Report and Notice of Meeting 2025
5th Jun 20252:00 pmRNSDirector/PDMR Shareholding
2nd Jun 202512:30 pmRNSTotal Voting Rights
28th May 202512:00 pmRNSDirector/PDMR Shareholding
27th May 202512:00 pmRNSDirector/PDMR Shareholding
23rd May 202510:00 amRNSDirector/PDMR Shareholding
22nd May 20257:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.